Metabolic Disorders and Cardiovascular Implications
Cover Page
Metabolic Disorders and Cardiovascular Implications
Student Name
Institution Affiliation
Course Name
Instructor Name
Assignment Due Date
Multiorgan Crosstalk in Cardiovascular Medicine
Defining Multiorgan Crosstalk in Cardiovascular Medicine
[Existing content unchanged]
Clinical Importance of the Heart–Kidney–Liver–Gut–Retina Axes
[Existing content unchanged]
Integrating Systemic Organ Interactions into Cardiovascular Risk Assessment
[Existing content unchanged]
Tănase's Contributions to Organ Crosstalk Research
[Existing content unchanged]
Cardiorenal Axis and Cardiovascular Disease
Pathophysiological Mechanisms Underlying Cardiorenal Syndrome
[Existing content unchanged]
Clinical Classification of Cardiorenal Syndromes
[Existing content unchanged]
Emerging Biomarkers and Therapeutic Strategies
[Existing content unchanged]
Molecular Mechanisms Driving Cardiorenal Injury
[Existing content unchanged]
Challenges in Volume Management
[Existing content unchanged]
Future Directions in Cardiorenal Research
[Existing content unchanged]
Cardiohepatic Axis in Metabolic Disease
Non-Alcoholic Fatty Liver Disease and Cardiovascular Risk
[Existing content unchanged]
Inflammatory Mediators, Hepatokines, and Atherosclerosis
[Existing content unchanged]
Ceramides as Mediators of Liver–Heart Injury
[Existing content unchanged]
Hypothyroidism-Induced Fatty Liver Disease and Cardiovascular Dysfunction
[Existing content unchanged]
Obesity, Branched-Chain Amino Acids, and Systemic Inflammation
[Existing content unchanged]
Gut–Heart Axis and Microbiome Dysbiosis
Gut Barrier Dysfunction and Immune Activation
[Existing content unchanged]
Trimethylamine-N-Oxide and Cardiovascular Risk
[Existing content unchanged]
Gut Dysbiosis in Type 2 Diabetes and Cardiovascular Disease
[Existing content unchanged]
Diagnostic and Therapeutic Applications of the Gut Microbiome
[Existing content unchanged]
Microvascular Crosstalk and Cardiovascular Risk
Diabetic Retinopathy as a Systemic Microvascular Biomarker
[Existing content unchanged]
Brain-Derived Neurotrophic Factor and Neurovascular Integrity
[Existing content unchanged]
Microvascular Dysfunction as a Driver of Macrovascular Disease
[Existing content unchanged]
Emerging Systemic Axes in Cardiovascular Pathophysiology
[Existing content unchanged]
References
[References preserved exactly as provided.]